426
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus–Acinetobacter baumannii complex

, , , , , & show all
Pages 370-378 | Received 07 Jun 2014, Accepted 26 Nov 2014, Published online: 06 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Matteo Bassetti, Laura Labate, Chiara Russo, Antonio Vena & Daniele Roberto Giacobbe. (2021) Therapeutic options for difficult-to-treat Acinetobacter baumannii infections: a 2020 perspective. Expert Opinion on Pharmacotherapy 22:2, pages 167-177.
Read now
Hongmei Shu, Lijuan Li, Yimin Wang, Yiqun Guo, Chunlei Wang, Chunxia Yang, Li Gu & Bin Cao. (2020) Prediction of the Risk of Hospital Deaths in Patients with Hospital-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii Infection: A Multi-Center Study. Infection and Drug Resistance 13, pages 4147-4154.
Read now
Kirsten Busey, Jason Ferreira, Petra Aldridge, Donald Johnson, Nilmarie Guzman & Christopher A. Jankowski. (2016) Treatment efficacy of Ampicillin/Sulbactam in comparison to alternative beta-lactams for severe Acinetobacter baumannii infections. Infectious Diseases 48:10, pages 775-777.
Read now

Articles from other publishers (7)

Sazlyna Mohd Sazlly Lim, Aaron J. Heffernan, Hosam M. Zowawi, Jason A. Roberts & Fekade B. Sime. (2021) Semi-mechanistic PK/PD modelling of meropenem and sulbactam combination against carbapenem-resistant strains of Acinetobacter baumannii. European Journal of Clinical Microbiology & Infectious Diseases 40:9, pages 1943-1952.
Crossref
Jiating Liu, Yunfeng Shu, Feilong Zhu, Bimin Feng, Zhengjie Zhang, Liang Liu & Guojun Wang. (2021) Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: A systematic review and network meta-analysis. Journal of Global Antimicrobial Resistance 24, pages 136-147.
Crossref
Sazlyna Mohd Sazlly Lim, Fekade Bruck Sime & Jason A. Roberts. (2019) Multidrug-resistant Acinetobacter baumannii infections: Current evidence on treatment options and the role of pharmacokinetics/pharmacodynamics in dose optimisation. International Journal of Antimicrobial Agents 53:6, pages 726-745.
Crossref
Hossein Khalili, Lida Shojaei, Mostafa Mohammadi, Mohammad-Taghi Beigmohammadi, Alireza Abdollahi & Mahsa Doomanlou. (2018) Meropenem/colistin versus meropenem/ampicillin–sulbactam in the treatment of carbapenem-resistant pneumonia. Journal of Comparative Effectiveness Research 7:9, pages 901-911.
Crossref
Su Young Jung, Seung Hee Lee, Soo Young Lee, Seungwon Yang, Hayeon Noh, Eun Kyoung Chung & Jangik I. Lee. (2017) Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis. Critical Care 21:1.
Crossref
Eric Wenzler, Debra A. Goff, Romney Humphries & Ellie J. C. Goldstein. (2017) Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections. Infectious Diseases and Therapy 6:2, pages 149-172.
Crossref
Jung-Jr Ye, Huang-Shen Lin, Chun-Fu Yeh, Yen-Mu Wu, Po-Yen Huang, Chien-Chang Yang, Ching-Tai Huang & Ming-Hsun Lee. (2016) Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex. BMC Infectious Diseases 16:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.